Vitamin E, selenium supplements did not prevent dementia

March 20, 2017
Credit: CC0 Public Domain

Antioxidant supplements vitamin E and selenium - taken alone or in combination - did not prevent dementia in asymptomatic older men, according to a study published online by JAMA Neurology.

Antioxidants as potential treatment for cognitive impairment or dementia have been of interest for years because has been implicated as a dementia pathway.

The Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADViSE) clinical trial initially enrolled 7,540 older men who used the supplements for an average of about five years and a subset of 3,786 men who agreed to be observed longer. The men received either vitamin E, , both or a placebo.

The incidence of dementia (325 of 7,338 men [4.4 percent]) was not different among the four study groups, according to the results in the article by Richard J. Kryscio, Ph.D., of the University of Kentucky, Lexington, and coauthors.

Limitations of the study include losing about half of the participants to long-term follow-up during the transition from a to a cohort study. Publicity about the negative effect of supplements also may have played a role, according to the authors.

"The supplemental use of vitamin E and selenium did not forestall dementia and are not recommended as preventive agents. This conclusion is tempered by the underpowered study, inclusion of only men, a short supplement exposure time, dosage considerations and methodologic limitations in relying on real-world reporting of incident cases," the article concludes.

Explore further: Vitamin E, selenium supplements unlikely to effect age-related cataracts in men

More information: JAMA Neurol. Published online March 20, 2017. DOI: 10.1001/jamaneurol.2016.5778

Related Stories

Cataract risk not down with long-tem selenium, vitamin E

January 9, 2015

(HealthDay)—Long-term supplementation with selenium or vitamin E is not associated with a reduction in the risk of age-related cataract among men, according to a study published in the January issue of JAMA Ophthalmology.

Recommended for you

Plant reveals anti-Alzheimer's compounds

June 20, 2017

Japanese scientists have developed a method to isolate and identify active compounds in plant medicines, which accurately accounts for drug behavior in the body. Using the technique, they have identified several active compounds ...

Rate of Alzheimer's deaths on the rise

June 15, 2017

The rate of death from Alzheimer's disease in the United States increased by more than 50 percent in the past 15 years, according to new data from the Centers for Disease Control and Prevention.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.